Last €66.40 EUR
Change Today +1.41 / 2.16%
Volume 0.0
4XS On Other Exchanges
Symbol
Exchange
4XS is not on other exchanges.
As of 1:36 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

express scripts holding co (4XS) Snapshot

Open
€65.02
Previous Close
€64.99
Day High
€66.47
Day Low
€65.02
52 Week High
12/10/14 - €69.02
52 Week Low
04/30/14 - €47.50
Market Cap
48.7B
Average Volume 10 Days
359.0
EPS TTM
--
Shares Outstanding
733.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EXPRESS SCRIPTS HOLDING CO (4XS)

express scripts holding co (4XS) Details

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. It operates in two segments, PBM and Other Business Operations. The company’s PBM services comprise retail network pharmacy administration; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management; clinical solutions to improve health outcomes; an array of Medicare Part D, Medicaid, and health insurance marketplace; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio- pharmaceutical services, including reimbursement and logistics solutions; group purchasing organization administration; and consumer health and drug information services. It is also involved in the distribution of pharmaceuticals and medical supplies to providers and clinics; development of scientific evidence to guide the use of medicines; and provision of case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. Express Scripts Holding Company provides its PBM services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, and government health programs; and specialty services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

29,975 Employees
Last Reported Date: 02/20/14
Founded in 1986

express scripts holding co (4XS) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Executive Vice President and General Counsel
Total Annual Compensation: $617.8K
Compensation as of Fiscal Year 2013.

express scripts holding co (4XS) Key Developments

Express Scripts Holding Company Announces Executive Changes

Express Scripts announced that it is initiating a Chief Financial Officer transition process. Cathy R. Smith will be leaving the company to pursue other interests and no longer serves in the role of Executive Vice President and Chief Financial Officer of the company. Ms. Smith will continue her employment into the first quarter of 2015 in order to facilitate a smooth and orderly transition. The company also announced that James M. Havel has been appointed to serve as Executive Vice President and Interim Chief Financial Officer effective January 2, 2015. Mr. Havel will join Express Scripts from Major Brands Holdings, where he has served as the Chief Financial Officer since April 2012. Previously, Mr. Havel owned and operated Havel Associates, LLC from July 2010 to April 2012.

Express Scripts Reaffirms Earnings Guidance for the Year 2014

Express Scripts reaffirmed earnings guidance for the year 2014. The company is reaffirming its adjusted earnings per diluted share guidance range of $4.86 to $4.90, which maintains the mid-point of $4.88. The guidance range reflects year over year growth of 18% to 19% excluding the impact of the roll-off of UnitedHealth Group claims or growth of 12% to 13%.

Three Pharmacies Suing Express Scripts over Rejected Claims Compounded Drugs for Denying Coverage of Compounded Drugs

Three out-of-state pharmacies are suing Express Scripts Holding Company for denying coverage of compounded drugs. The suit, filed in the U.S. District Court in St. Louis, alleges that Express Scripts is trying to cut costs by denying payments to pharmacies for compounded drugs, which are mixed and prepared at certain pharmacies per a doctor's order. The lawsuit alleges the compound drugs were previously covered, and that denials started occurring this past June. The plaintiffs are Texas-based Annie's Apothecary; Cypress Compounding Pharmacy, also in Texas; and Louisiana-based Mason's Pharmacy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4XS:GR €66.40 EUR +1.41

4XS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anthem Inc $127.95 USD +0.24
Cardinal Health Inc $83.04 USD +0.63
McKesson Corp $211.12 USD -0.85
Kroger Co/The $63.55 USD -0.09
Walgreen Co $73.23 USD -1.15
View Industry Companies
 

Industry Analysis

4XS

Industry Average

Valuation 4XS Industry Range
Price/Earnings 32.2x
Price/Sales 0.6x
Price/Book 2.9x
Price/Cash Flow 15.4x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit www.express-scripts.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.